170 related articles for article (PubMed ID: 35738865)
1. Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas.
Weishaupt H; Čančer M; Rosén G; Holmberg KO; Häggqvist S; Bunikis I; Jiang Y; Sreedharan S; Gyllensten U; Becher OJ; Uhrbom L; Ameur A; Swartling FJ
Neuro Oncol; 2023 Jan; 25(1):97-107. PubMed ID: 35738865
[TBL] [Abstract][Full Text] [Related]
2. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.
Johansson FK; Göransson H; Westermark B
Oncogene; 2005 Jun; 24(24):3896-905. PubMed ID: 15750623
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging.
Johansson FK; Brodd J; Eklöf C; Ferletta M; Hesselager G; Tiger CF; Uhrbom L; Westermark B
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11334-7. PubMed ID: 15273287
[TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells.
Zhang L; Laaniste L; Jiang Y; Alafuzoff I; Uhrbom L; Dimberg A
Oncotarget; 2016 Dec; 7(49):80382-80390. PubMed ID: 27806344
[TBL] [Abstract][Full Text] [Related]
6. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma.
Põlajeva J; Swartling FJ; Jiang Y; Singh U; Pietras K; Uhrbom L; Westermark B; Roswall P
BMC Cancer; 2012 Aug; 12():378. PubMed ID: 22931209
[TBL] [Abstract][Full Text] [Related]
7. Identifying candidate genes involved in brain tumor formation.
Johansson Swartling F
Ups J Med Sci; 2008; 113(1):1-38. PubMed ID: 18521796
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
Gressot LV; Doucette TA; Yang Y; Fuller GN; Heimberger AB; Bögler O; Rao A; Latha K; Rao G
Int J Cancer; 2015 May; 136(9):2047-54. PubMed ID: 25302990
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma.
Ross JL; Chen Z; Herting CJ; Grabovska Y; Szulzewsky F; Puigdelloses M; Monterroza L; Switchenko J; Wadhwani NR; Cimino PJ; Mackay A; Jones C; Read RD; MacDonald TJ; Schniederjan M; Becher OJ; Hambardzumyan D
Brain; 2021 Feb; 144(1):53-69. PubMed ID: 33300045
[TBL] [Abstract][Full Text] [Related]
10. Persistent roles of signal transduction of platelet-derived growth factor B in genesis, growth, and anaplastic transformation of gliomas in an in-vivo serial transplantation model.
Torisu R; Suzuki SO; Masui K; Yoshimoto K; Mizoguchi M; Hashizume M; Canoll P; Goldman JE; Sasaki T; Iwaki T
Brain Tumor Pathol; 2011 Feb; 28(1):33-42. PubMed ID: 21210235
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
[TBL] [Abstract][Full Text] [Related]
12. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
13. Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence.
Tchougounova E; Jiang Y; Bråsäter D; Lindberg N; Kastemar M; Asplund A; Westermark B; Uhrbom L
Oncogene; 2009 Mar; 28(12):1537-48. PubMed ID: 19219070
[TBL] [Abstract][Full Text] [Related]
14. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
[TBL] [Abstract][Full Text] [Related]
15. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
16. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma.
Becker H; Castaneda-Vega S; Patzwaldt K; Przystal JM; Walter B; Michelotti FC; Canjuga D; Tatagiba M; Pichler B; Beck SC; Holland EC; la Fougère C; Tabatabai G
Brain Sci; 2022 Oct; 12(11):. PubMed ID: 36358353
[TBL] [Abstract][Full Text] [Related]
18. SCCRO promotes glioma formation and malignant progression in mice.
Broderick SR; Golas BJ; Pham D; Towe CW; Talbot SG; Kaufman A; Bains S; Huryn LA; Yonekawa Y; Carlson D; Hambardzumyan D; Ramanathan Y; Singh B
Neoplasia; 2010 Jun; 12(6):476-84. PubMed ID: 20563250
[TBL] [Abstract][Full Text] [Related]
19. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.
Doucette T; Yang Y; Zhang W; Fuller GN; Suki D; Fults DW; Rao G
Int J Cancer; 2011 Nov; 129(9):2093-103. PubMed ID: 21171016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
